title: Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.
authors.affiliation: Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
authors.forename: Sana
authors.initials: S
authors.lastname: Khan
authors.affiliation: Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia wkb5s@virginia.edu.
authors.forename: W Kline
authors.initials: WK
authors.lastname: Bolton
mesh_terms: D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D009369:Neoplasms / Q000453:epidemiology*
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide
keywords: cancer; cyclophosphamide; membranous nephropathy